Find trials
Search tips

AI Algorithm for Detection of Pancreatic Ductal Adenocarcinoma

Overview

About this study

The purpose of this study is to evaluate an artificial intelligence (AI) algorithm, developed for detection of pancreatic ductal adenocarcinoma (PDA), on contrast enhanced abdomen CT scans requested by referring providers as a part of clinically indicated examinations.    

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients

  • CT Abdomen imaging.   

Physicians:

  • Members of Mayo Clinic’s radiology departments across the enterprise.

Exclusion Criteria:

Patients

  • Suboptimal quality CT acquisition (noise, motion, etc).

  Physicians 

  • None.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/10/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ajit Goenka, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20562444

Mayo Clinic Footer